Lazola, Narcisa A.

HRN: 10-05-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2025
CEFTRIAXONE 1G (VIAL)
11/13/2025
11/20/2025
IV
2g
OD
CAP MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines